Abstract:A central role for vitamin D (VD) in immune modulation has recently been recognized linking VD insufficiency to autoimmune disorders that commonly exhibit sex-associated differences. Similar to other autoimmune diseases, there is a higher incidence of multiple sclerosis (MS) in women, but a poorer prognosis in men, often characterized by a more rapid progression. Although sex hormones are most likely involved, this phenomenon is still poorly understood. Oxidative stress, modulated by VD serum levels as well as sex hormones, may act as a contributing factor to demyelination and axonal damage in both MS and the corresponding preclinical models. In this study, we analyzed sex-associated differences and VD effects utilizing an animal model that recapitulates histopathological features of the progressive MS phase (PMS). In contrast to relapsing–remitting MS (RRMS), PMS has been poorly investigated in this context. Male (n = 50) and female (n = 46) Dark Agouti rats received either VD (400 IU per week; VD+) or standard rodent food without extra VD (VD−) from weaning onwards. Myelination, microglial activation, apoptotic cell death and neuronal viability were assessed using immunohistochemical markers in brain tissue. Additionally, we also used two different histological markers against oxidized lipids along with colorimetric methods to measure protective polyphenols (PP) and total antioxidative capacity (TAC) in serum. Neurofilament light chain serum levels (sNfL) were analyzed using single-molecule array (SIMOA) analysis. We found significant differences between female and male animals. Female rats exhibited a better TAC and higher amounts of PP. Additionally, females showed higher myelin preservation, lower microglial activation and better neuronal survival while showing more apoptotic cells than male rats. We even found a delay in reaching the peak of the disease in females. Overall, both sexes benefitted from VD supplementation, represented by significantly less cortical, neuroaxonal and oxidative damage. Unexpectedly, male rats had an even higher overall benefit, most likely due to differences in oxidative capacity and defense systems.

Functional genomics analysis of vitamin D effects on CD4+ T cells in vivo in experimental autoimmune encephalomyelitis ‬

Full spectrum of vitamin D immunomodulation in multiple sclerosis: mechanisms and therapeutic implications

Vitamin D3-mediated resistance to a multiple sclerosis model disease depends on myeloid cell 1,25-dihydroxyvitamin D3 synthesis and correlates with increased CD4+ T cell CTLA-4 expression

Transcriptomics identifies blunted immunomodulatory effects of vitamin D in people with multiple sclerosis

The immune cell transcriptome is modulated by vitamin D3 supplementation in people with a first demyelinating event participating in a randomized placebo-controlled trial

CITE-seq reveals inhibition of NF-κB pathway in B cells from vitamin D-treated multiple sclerosis patients

Effect on Cytokine Profile in Multiple Sclerosis

Vitamins A and D Enhance the Expression of Ror-γ-Targeting miRNAs in a Mouse Model of Multiple Sclerosis

Multiple sclerosis and vitamin D: an update

Vitamin D affects the risk of disease activity in multiple sclerosis

Association of Vitamin D Metabolism Gene Polymorphisms with Autoimmunity: Evidence in Population Genetic Studies

Vitamin D Therapy in Experimental Allergic Encephalomyelitis Could Be Limited by Opposing Effects of Sphingosine 1-Phosphate and Gelsolin Dysregulation

Vitamin D Supplementation in Multiple Sclerosis: A Critical Analysis of Potentials and Threats

Therapeutic Role of Vitamin D in Multiple Sclerosis: An Essentially Contested Concept

Vitamin D3 Receptor Polymorphisms Regulate T Cells and T Cell-Dependent Inflammatory Diseases.

Causal association of genetically determined circulating vitamin D metabolites and calcium with multiple sclerosis in participants of European descent

The role of Vitamin D through SphK1/S1P in the regulation of MS progression

Vitamin D as a Risk Factor for Multiple Sclerosis: Immunoregulatory or Neuroprotective?

Sex Differences under Vitamin D Supplementation in an Animal Model of Progressive Multiple Sclerosis

Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis